Findings were communicated to the medicines optimisation team across primary and secondary care settings to drive the development of a concise patient information leaflet (PIL). RESULTS. Among the 100 patients receiving SGLT2i (mean age 72.5卤12.8 years, 75% male), 53 were prescribed for HF (...
Unlike with other antidiabetic drugs, such as metformin or glimepiride, with impaired renal function there is no risk to the patient, but the treatment becomes gradually ineffective. As a consequence, canagliflozin therapy should not be initiated in patients with end-stage renal disease, on ...